Strategies to optimize your intake The take-home message is quality, dose and delivery form, and duration matter, and they matter a lot
doi:10.1016/j.ijgo.2015.04.046 37Qublan HS, Al-Khaderei S, Abu-Salem AN, et al
In a Phase 2 clinical trial published in the New England Journal of Medicine in 2023 (Jastreboff et al
"Today, they're a fully loaded magazine of silver bullets aimed at obesity, addiction, cancer, sleep apnea, and a growing list of other diseases and chronic conditions." Here's what Galloway had to say about which GLP-1 producers make for a good investment and what needs to change for GLP-1s to be even more successful
Clinical studies of Tesamorelin have reported reductions in visceral adipose tissue and improvements in body composition measures